Pathozone 250 mg ενδομαστικό εναιώρημα για αγελάδες
Pathozone 250 mg ενδομαστικό εναιώρημα για αγελάδες
Authorised
- Cefoperazone
Product identification
Medicine name:
Pathozone 250 mg ενδομαστικό εναιώρημα για αγελάδες
Active substance:
- Cefoperazone
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefoperazone250.00/milligram(s)10.00millilitre(s)
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (lactating cow)
-
Milk96hour
-
Meat2day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DD12
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- 12143
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 26/08/2022